Evidence map›Paper›PMID 42919388›Full record

ReviewFluids and barriers of the CNS2026

Blood-brain barrier and blood-tumoral barrier formation in glioblastoma: endothelial cells and glioblastoma stem cells at the immune-brain crossroad.

Maria Rosito, Ruth Lyck, Britta Engelhardt, Cristina Limatola

Abstract readReview
PubMed Publisher
In one paragraph

Review in Fluids and barriers of the CNS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maria RositoDepartment of Life Sciences, Health and Health Professions, Link Campus University, 00165, Roma, Italy. maria.rosito@gmail.com.
Ruth LyckTheodor Kocher Institute, University of Bern, Bern, 3012, Switzerland.
Britta EngelhardtTheodor Kocher Institute, University of Bern, Bern, 3012, Switzerland.
Cristina LimatolaDepartment of Physiology and Pharmacology, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, 00185, Rome, Italy.

Funding

Associazione Italiana per la Ricerca sul Cancro AIRC2025-IG32026
6 · The paper itself

Abstract

Glioblastoma (GBM) is the most aggressive primary brain tumor characterized by significant cellular and molecular complexity. Central to this complexity are glioma stem cells (GSCs) and the perivascular niche, a specialized microenvironment that integrates signals from the systemic circulation with cues arising from tumor development. Acting as a regulatory hub, the perivascular niche influences GSC proliferation, migration, and resistance to therapy through multiple interactions among vascular, immune, and tumor cell populations. In this review, we focus on GSCs and examine the cellular composition and molecular mechanisms operating within the perivascular niche, highlighting key modes of crosstalk that sustain tumor progression. We furthermore critically evaluate experimental strategies used to study this compartment, including 2D and 3D cell cultures, organoids, and in vivo models, discussing their respective strengths and limitations for testing intercellular interactions and therapeutic approaches. A comprehensive understanding of tumor heterogeneity and the interactions between different tumor cell populations, combined with well-characterized experimental models, is essential for deriving mechanistic insights and informing the development of more effective targeted therapies for GBM, ultimately advancing our knowledge of how tumor-microenvironment interactions drive GBM progression.

Indexed as

Blood-Brain BarrierBrain NeoplasmsEndothelial CellsGlioblastomaNeoplastic Stem CellsTumor MicroenvironmentAnimalsHumans3D in vitro modelsBlood–brain barrierBlood–tumor barrierEndothelial cellsGlioblastoma stem cellsImmune–brain crosstalkMicrofluidic platformsPerivascular nicheTumor microenvironmentTumor microtubesTunneling nanotubesVascular remodeling

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.